1. Katchen, B. and Symchowicz, S. (1967) Correlation of dissolution rate and griseofulvin absorption in man. J. Pharm. Sci. 56, 1108–1110.
2. Al-Saieq, S.S. and Riley, G.S. (1982) Polymorphism in sulphonylurea hypoglycaemic agents: II. chlorpropamide. Pharm. Acta Helv. 57, 8–11.
3. Haleblian, J. and McCrone, W. (1969) Pharmaceutical applications of polymorphism. J. Pharm. Sci. 58, 911–929.
4. Dresse, A., Gérard, M.A., Lays, A., Tempero, K.F. and Verhaest, L. (1978) Human pharmacokinetics of two crystalline and galenic forms of diflunisal, a new analgesic. Pharm. Acta Helv. 53, 177–181.
5. Aguiar, A.J., Krc, J., Kinkel, A.W. and Samyn, J.C. (1967) Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. J. Pharm. Sci. 56, 847–853.